Steven R. Altman, Director at DEXCOM INC (DXCM), sold 2,000 shares at $122.77 ($246K) on 2023-12-15, disclosed to the SEC on 2023-12-18.
Scheduled sale ($246k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DXCM | SELL | 2023-11-15 | $101K | — | Filing → |
| DXCM | SELL | 2023-10-17 | $78K | — | Filing → |
| DXCM | SELL | 2023-09-19 | $102K | — | Filing → |